about
sameAs
Human hallucinogen research: guidelines for safetyToxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literatureRecreational drug misuse: issues for the cardiologistPractical guide to the management of acute and chronic pain in the presence of drug tolerance for the healthcare practitioner.Treatment of alcoholism using psychedelic drugs: a review of the program of research.Indolealkylamines: biotransformations and potential drug-drug interactions'Visual snow' - a disorder distinct from persistent migraine aura.LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series.A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs.Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.[The substance experience, a history of LSD].Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.Drugs, discourses and education: a critical discourse analysis of a high school drug education text
P2860
Q24600704-3622F184-3EA9-47A3-B51B-03FB08D528C4Q26865329-4CF51249-B5C2-4F8D-AEDE-8F9C1BE4F10AQ33920595-919D6C75-D256-4645-9D3F-647B04595985Q34228635-052EF4C5-AA35-48C3-BA99-15BAFE4AAC6AQ34489981-9DA8D551-E15E-486A-8B5E-41E257FEE8CEQ34775667-8A3294BF-714D-4F53-B001-AACB4AD40291Q38197183-9E34B262-43A3-494B-BDE6-431CB6838D6CQ38373370-523910A7-9A0B-4437-AF35-ED668BD47931Q38575828-DD868541-3F04-4BDA-88B0-11C37299869BQ38797612-447F7875-3C2E-4C45-95B6-58CB6F6F11D8Q42735259-FA57BE51-7054-4F6F-9792-D38369EA3746Q44697721-A1ED7EA6-D467-4D74-B925-0310992166FCQ46566134-EFAE1198-CD8D-4666-BA13-B2BDD6A38AA4Q47675823-3098A51F-62E9-4074-B884-8D3BAF48DF0DQ47682925-ED85B3DF-10DE-4233-9CA3-4691C238FE8DQ55080181-68528828-D580-4D56-A37A-EAF21331CA1FQ56699008-3368FD35-B4FB-438B-B75A-A4EDF30D027A
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Adverse consequences of lysergic acid diethylamide
@ast
Adverse consequences of lysergic acid diethylamide
@en
Adverse consequences of lysergic acid diethylamide
@en-gb
Adverse consequences of lysergic acid diethylamide.
@nl
type
label
Adverse consequences of lysergic acid diethylamide
@ast
Adverse consequences of lysergic acid diethylamide
@en
Adverse consequences of lysergic acid diethylamide
@en-gb
Adverse consequences of lysergic acid diethylamide.
@nl
altLabel
Adverse consequences of lysergic acid diethylamide.
@ast
Adverse consequences of lysergic acid diethylamide.
@en
prefLabel
Adverse consequences of lysergic acid diethylamide
@ast
Adverse consequences of lysergic acid diethylamide
@en
Adverse consequences of lysergic acid diethylamide
@en-gb
Adverse consequences of lysergic acid diethylamide.
@nl
P2093
P2860
P1433
P1476
Adverse consequences of lysergic acid diethylamide
@en
Adverse consequences of lysergic acid diethylamide.
@en
P2093
ANDREW M. ALDRIDGE
Abraham HD
Aldridge AM
HENRY DAVID ABRAHAM
P2860
P304
P356
10.1111/J.1360-0443.1993.TB02018.X
P407
P577
1993-10-01T00:00:00Z